1
Rats. Eur J Pharmacol 2004, 503:135?45.van den Brom et al. Cardiovascular Diabetology 2013, 12:42 http://www.cardiab.com/content/12/1/Page 12 of95. Mouquet F, Rousseau D, Domergue-Dupont V, Grynberg A, Liao R: Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat. Fundam Clin Pharmacol 2010